Scientific article

Actualités thérapeutiques en orthopédie septique

Other title[Management of bone and joint infections: update]
Published inRevue médicale suisse, vol. 19, no. 822, p. 714-718
Publication date2023-04-12

This article highlights four recent updates in infectious disease in the management of bone and joint infections (BJI). During the first six weeks of treatment of a BJI, with or without orthopedic implant, oral antimicrobial therapy is as effective as intravenous therapy. For periprosthetic joint infections, a randomized control study failed to demonstrate non-inferiority of 6 versus 12 weeks of antibiotic therapy. In diabetic foot osteomyelitis, a 3-week course of antibiotics appears to be non-inferior to a 6-week course. Phage therapy seems promising in adjunctive therapy of complex BJI.

  • Humans
  • Communicable Diseases / drug therapy
  • Arthritis, Infectious / drug therapy
  • Osteomyelitis / therapy
  • Anti-Bacterial Agents / therapeutic use
  • Diabetic Foot / drug therapy
Citation (ISO format)
BARROCO, Clara et al. Actualités thérapeutiques en orthopédie septique. In: Revue médicale suisse, 2023, vol. 19, n° 822, p. 714–718. doi: 10.53738/REVMED.2023.19.822.714
Main files (1)
Article (Published version)
accessLevelRestrictedaccessLevelPublic 10/13/2024
ISSN of the journal1660-9379

Technical informations

Creation04/27/2023 1:15:51 PM
First validation01/30/2024 5:31:17 PM
Update time01/30/2024 5:31:17 PM
Status update01/30/2024 5:31:17 PM
Last indexation01/30/2024 5:31:18 PM
All rights reserved by Archive ouverte UNIGE and the University of GenevaunigeBlack